Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer

Scientific Reports
Jin ShengLi Zhang

Abstract

The effects of treatments to programmed death ligand-1 (PD-L1) expression is unknown. The aim of this study was to investigate the impact of neoadjuvant chemotherapy (NACT) on PD-L1 expression in non-small cell lung cancer (NSCLC) patients. PD-L1 expression was detected by immunohistochemistry (IHC) method in 32 paired tumor specimens pre and post-NACT. The positivity of PD-L1 on tumor cells (TCs) changed from 75% to 37.5% after NACT (p = 0.003). Cases with IHC score of 1, 2, 3 all underwent apparent decrease (p = 0.007). However, no significant changes were observed on tumour-infiltrating immune cells (ICs) (p = 0.337). Subgroup and semiquantitative analyses all presented similar results. Moreover, patients with response to NACT presented significantly reduced PD-L1 expression on TCs (p = 0.004). Although it was not confirmed by the Cox proportional hazard regression model, there was an apparent difference in disease-free-survival (DFS) between negative-to-positive switch of PD-L1 status and the contrary group (median DFS: 9.6 versus 25.9, p = 0.005). Our data revealed that antecedent chemotherapy for NSCLC may results in inconsistency of PD-L1 expression. PD-L1 expression is suggested to be monitored around treatment and on s...Continue Reading

References

Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jun KonishiMasaharu Nishimura
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Junzo HamanishiShingo Fujii
Oct 3, 2007·The Journal of Clinical Investigation·Sophie SunJohn D Minna
Dec 22, 2007·Nature Reviews. Immunology·Laurence ZitvogelGuido Kroemer
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qiang GaoJia Fan
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jun 24, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jun YangMohamed H Sayegh
Jan 13, 2012·Current Opinion in Immunology·Suzanne L TopalianDrew M Pardoll
Feb 4, 2012·Nature Reviews. Drug Discovery·Lorenzo GalluzziGuido Kroemer
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jan 9, 2014·Hematology/oncology and Stem Cell Therapy·Sehar Afreen, Said Dermime
Feb 20, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ching-Yao YangPan-Chyr Yang
Jul 11, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K AzumaI Okamoto
Feb 7, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nan ChenLi Zhang
Feb 20, 2015·Molecular Cancer Therapeutics·Sandip Pravin Patel, Razelle Kurzrock
Mar 24, 2015·Future Oncology·Julie R BrahmerEvan J Lipson
May 31, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Wendy A CooperRichard A Scolyer
Jul 3, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Keith M KerrUNKNOWN IASLC Pathology Committee

❮ Previous
Next ❯

Citations

Nov 12, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jamaal A RehmanDavid L Rimm
Feb 6, 2017·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Diego Antonio Costa ArantesAline Carvalho Batista
Feb 22, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sehui KimDoo Hyun Chung
Feb 19, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kazuki TakadaYoshihiko Maehara
May 8, 2018·Cancers·Federica Lo SardoGiovanni Blandino
Sep 4, 2018·Future Oncology·Ajaz Bulbul, Emilio Araujo-Mino
Oct 3, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·Mohamad Mazen GafeerCynthia Cohen
Jan 9, 2019·Journal of Cancer Research and Clinical Oncology·Marco GalloUNKNOWN NIKE Group
Jan 19, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R S HerbstE B Garon
Feb 15, 2019·Expert Opinion on Biological Therapy·Martyna FilipskaRafael Rosell
Apr 20, 2019·Acta Oncologica·Lilla ReinigerJudit Moldvay
Nov 11, 2017·British Journal of Cancer·Jessica S BrownJuanita Lopez
Nov 16, 2018·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Junghoon ShinJong-Seok Lee
Dec 12, 2018·Current Cancer Drug Targets·Tatsuya NaganoYoshihiro Nishimura
Aug 18, 2016·Journal for Immunotherapy of Cancer·Claud Grigg, Naiyer A Rizvi
Apr 21, 2018·Journal of Cancer Research and Clinical Oncology·Lívia RojkóJudit Moldvay
Jun 4, 2018·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Ji Hyun YangIn-Ho Kim
Jun 15, 2017·Annals of the American Thoracic Society·Edmund K MoonSteven M Albelda
Feb 2, 2018·Therapeutic Advances in Respiratory Disease·Prantesh JainVamsidhar Velcheti
Feb 24, 2018·Expert Opinion on Biological Therapy·Sheik EmambuxDavid Tougeron
Sep 18, 2018·Oncoimmunology·Adrien CostantiniEtienne Giroux Leprieur
May 15, 2018·American Journal of Respiratory and Critical Care Medicine·Jason BeattieUNKNOWN ATS Assembly on Thoracic Oncology
Aug 31, 2018·International Journal of Clinical Oncology·Katsuyuki HottaKatsuyuki Kiura
May 20, 2020·Journal of Experimental & Clinical Cancer Research : CR·Filippo GalliAlberto Signore
Sep 25, 2018·Briefings in Functional Genomics·Ya-Fei YanYao-Gui Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
surgical resection

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
A SantoG L Cetto
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
D D'UgoR Ricci
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Li-Bing LuPing Zhang
© 2021 Meta ULC. All rights reserved